Eating disorders in the 21st century: identification, management, and prevention in obstetrics and gynecology

被引:10
作者
Zerbe, Kathryn J. [1 ]
机构
[1] Oregon Hlth & Sci Univ, Dept Psychiat, Outpatient Serv, Portland, OR 97239 USA
关键词
anorexia; bulimia; co-morbidity; integrated treatment; screening; mortality; psychopharmacology; pregnancy;
D O I
10.1016/j.bpobgyn.2006.12.001
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Eating disorders are extremely common and carry a high degree of medical and psychiatric morbidity. These disorders are challenging to treat because many patients deny their symptoms, have poor motivation to change, and can become frustrating to the clinician. Case identification based upon suggested screening questions and ongoing management of medical consequences are important roles for the obstetrician/gynecologist involved in the care of these patients. This chapter discusses the benefits and limitations of contemporary treatment, special populations at risk (e.g. athletes, diabetics), and screening guidelines for office practice. Signs, symptoms, laboratory abnormalities, and the perils of associated psychiatric illness are briefly reviewed. Patients do respond to a comprehensive, integrated treatment plan that includes nutritional stabilization, psychotherapy, and pharmacotherapy. Collaboration between all professionals involved in the patient's care is essential for state-of-the-art care. Those patients who become pregnant or wish to become pregnant pose certain additional treatment considerations. Ongoing and future research aimed at understanding how eating disorders develop - and may be prevented by early identification and education - will result in enhanced knowledge of these life-threatening and often chronic illnesses in the 21st century.
引用
收藏
页码:331 / 343
页数:13
相关论文
共 58 条
  • [21] Compulsive physical activity in adolescents with anorexia nervosa - A psychobehavioral spiral of pathology
    Davis, C
    Katzman, DK
    Kirsh, C
    [J]. JOURNAL OF NERVOUS AND MENTAL DISEASE, 1999, 187 (06) : 336 - 342
  • [22] Eisler I, 1997, ARCH GEN PSYCHIAT, V54, P1025
  • [23] FERRI F, 2005, FERRIS CLIN ADVISOR, P71
  • [24] Forman Maryelizabeth, 2005, Eat Disord, V13, P231
  • [25] Pregnancy complications and neonatal outcomes in women with eating disorders
    Franko, DL
    Blais, MA
    Becker, AE
    Delinsky, SS
    Greenwood, DN
    Flores, AT
    Ekeblad, ER
    Eddy, KT
    Herzog, DB
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2001, 158 (09) : 1461 - 1466
  • [26] Golden Neville H, 2003, Adolesc Med, V14, P97
  • [27] Alendronate for the treatment of osteopenia in anorexia nervosa: A randomized, double-blind, placebo-controlled trial
    Golden, NH
    Iglesias, EA
    Jacobson, MS
    Carey, D
    Meyer, W
    Schebendach, J
    Hertz, S
    Shenker, IR
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (06) : 3179 - 3185
  • [28] Gordon RA., 2000, EATING DISORDERS ANA, P281
  • [29] Efficacy of cognitive behavioral therapy and fluoxetine for the treatment of binge eating disorder: A randomized double-blind placebo-controlled comparison
    Grilo, CM
    Masheb, RM
    Wilson, GT
    [J]. BIOLOGICAL PSYCHIATRY, 2005, 57 (03) : 301 - 309
  • [30] Effects of recombinant human IGF-1 and oral contraceptive administration on bone density in anorexia nervosa
    Grinspoon, S
    Thomas, L
    Miller, K
    Herzog, D
    Klibanski, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (06) : 2883 - 2891